Tag:
Sanofi
Latest Headlines
Latest Headlines
Sanofi eyes Chinese cancer market with early drug trial
Sanofi CEO Chris Viehbacher is betting that an experimental liver cancer drug could make big inroads in China.
Sanofi chief highlights high hopes for liver cancer drug
Sanofi CEO Chris Viehbacher said that investigators would push ahead with the first human studies of the therapy next year.
Pharma giants join forces on $285M antibiotics collaboration
GlaxoSmithKline, Sanofi, AstraZeneca, J&J as well as Basilea will join an R&D consortium including Europe's Innovative Medicines Initiative to fund the effort, setting up an information hub that will share data among investigators laboring on new antibiotics.
Another one bites the dust: Plavix falls off patent today
Yet another milestone on pharma's journey away from the megablockbuster era: Plavix, the gold-standard clotbuster, goes off patent today.
Buzz: Big Pharma suitors line up for a look at Amylin's books
One of the cardinal rules involved in deal-making focuses on the need to get as many buyers to the negotiating table as possible. The next big rule: Make sure everyone knows who's interested in bidding.
Shantha gets go-ahead for operational revamp
Sanofi's plan for revamping Shantha Biotech won Indian government approval, clearing the way for it to recapture WHO contracts for its Shan5 vaccine.
Indian gov't probes drug regulator after scathing review
Days after a parliamentary report noted shoddy oversight of approvals, the Indian government has mounted an investigation into the alleged misdeeds. Meanwhile, big names in biopharma have surfaced in the sea of allegations.
Indian panel accuses Big Pharma of colluding with regulators
An Indian government report has hit the domestic pharma business like a whirlwind--and sucked Big Pharma into the fury.
Subpar clinical trials probed in India's review of regulation
Indian lawmakers and patient advocates charge that their regulator rubber-stamped drugs to be sold in the county without required clinical trials.
Ex-Sanofi chemist locked up after theft
After being accused of bilking her former employer, a court sentenced ex-Sanofi chemist Yuan Li to serve a year and half in prison and pay $131,000 in restitution, Pharmalot reported, citing court documents.
